Question about recent expansion. -s/c patients
Post# of 148291
-s/c patients in trial site hospitals can now get leronlimab.
-Patients in other hospitals, via eIND process, may also get leronlimab.
Will the results of either/both be public knowledge immediately?
Or will the FDA keep a lid on it, until trial results are released?
why/why not?